Business Description
HCmed Innovations Co Ltd
ISIN : TW0006934003
Description
HCmed Innovations Co Ltd is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product include Pulmogine and AdheResp.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 13.62 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.09 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 23.78 | |||||
| Beneish M-Score | -3.19 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.83 | |||||
| 9-Day RSI | 56.03 | |||||
| 14-Day RSI | 54.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.72 | |||||
| Quick Ratio | 5.66 | |||||
| Cash Ratio | 5.26 | |||||
| Days Inventory | 48.96 | |||||
| Days Sales Outstanding | 8.25 | |||||
| Days Payable | 6.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -11.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -64.43 | |||||
| Operating Margin % | -586.43 | |||||
| Net Margin % | -670.67 | |||||
| FCF Margin % | -478.06 | |||||
| ROE % | -82.57 | |||||
| ROA % | -68.95 | |||||
| ROIC % | -160.43 | |||||
| ROC (Joel Greenblatt) % | -522.47 | |||||
| ROCE % | -79.5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 85.05 | |||||
| PB Ratio | 10.33 | |||||
| Price-to-Tangible-Book | 12.07 | |||||
| EV-to-EBIT | -12.04 | |||||
| EV-to-EBITDA | -14.08 | |||||
| EV-to-Revenue | 80.79 | |||||
| EV-to-FCF | -16.53 | |||||
| Price-to-Net-Current-Asset-Value | 14.98 | |||||
| Price-to-Net-Cash | 16.63 | |||||
| Earnings Yield (Greenblatt) % | -8.32 | |||||
| FCF Yield % | -5.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HCmed Innovations Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 25.555 | ||
| EPS (TTM) (NT$) | -6.05 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 54.2 | ||
| 14-Day ATR (NT$) | 1.524378 | ||
| 20-Day SMA (NT$) | 73.775 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (NT$) | 64.7 - 80.1 | ||
| Shares Outstanding (Mil) | 30.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HCmed Innovations Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HCmed Innovations Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
HCmed Innovations Co Ltd Frequently Asked Questions
What is HCmed Innovations Co Ltd(ROCO:6934)'s stock price today?
The current price of ROCO:6934 is NT$74.00. The 52 week high of ROCO:6934 is NT$80.10 and 52 week low is NT$64.70.
When is next earnings date of HCmed Innovations Co Ltd(ROCO:6934)?
The next earnings date of HCmed Innovations Co Ltd(ROCO:6934) is .
Does HCmed Innovations Co Ltd(ROCO:6934) pay dividends? If so, how much?
HCmed Innovations Co Ltd(ROCO:6934) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers